rs41298133
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000409709.9(MYO7A):c.700C>T(p.Gln234Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,613,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Q234Q) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000409709.9 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO7A | NM_000260.4 | c.700C>T | p.Gln234Ter | stop_gained | 7/49 | ENST00000409709.9 | NP_000251.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.700C>T | p.Gln234Ter | stop_gained | 7/49 | 1 | NM_000260.4 | ENSP00000386331 | ||
MYO7A | ENST00000458637.6 | c.700C>T | p.Gln234Ter | stop_gained | 7/49 | 1 | ENSP00000392185 | P1 | ||
MYO7A | ENST00000409619.6 | c.667C>T | p.Gln223Ter | stop_gained | 8/50 | 1 | ENSP00000386635 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152262Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000361 AC: 9AN: 248974Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135112
GnomAD4 exome AF: 0.0000239 AC: 35AN: 1461530Hom.: 0 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 727042
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152380Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74506
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 23, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 16, 2022 | ClinVar contains an entry for this variant (Variation ID: 11848). This premature translational stop signal has been observed in individuals with autosomal recessive Usher syndrome (PMID: 22219650, 29490346). This variant is present in population databases (rs41298133, gnomAD 0.009%). This sequence change creates a premature translational stop signal (p.Gln234*) in the MYO7A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYO7A are known to be pathogenic (PMID: 8900236, 25404053). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 28, 2023 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 22344438, 25525159, 7870171, 29490346, 31456290, 27610647, 27460420, 34948090, 32747562, 22219650, 21436283, 35076463) - |
Usher syndrome type 1B Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 10, 1995 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Dec 28, 2020 | - - |
Autosomal recessive nonsyndromic hearing loss 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | research | King Laboratory, University of Washington | Aug 01, 2020 | MYO7A c.700C>T, p.Q234* is homozygous in two children from 2 Palestinian families with pre-lingual hearing loss (Abu Rayyan 2020). The variant is absent from 1300 Palestinian controls and absent from gnomAD v2.1.1. - |
Usher syndrome type 1;C1838701:Autosomal recessive nonsyndromic hearing loss 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Sep 15, 2017 | - - |
Usher syndrome type 1 Pathogenic:1
Pathogenic, no assertion criteria provided | research | Sharon lab, Hadassah-Hebrew University Medical Center | Jun 23, 2019 | - - |
Rare genetic deafness Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 11, 2010 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at